PTGS2 and COVID-19: According to another report, there were 144 potential therapeutic targets of XBJ against COVID-19, of which GAPDH, TNF, CASP3, EGFR, MAPK1, PTGS2, STAT3, and MAPK8 had high degree values by PPI network analysis.